Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteria.

Eur J Clin Microbiol Infect Dis

Department of Microbiology, Karolinska Institute, Huddinge University Hospital, Sweden.

Published: November 1992

Three beta-lactamase inhibitors in clinical use--clavulanic acid, sulbactam and tazobactam--were investigated for their activity on beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum. Purification of the beta-lactamases was carried out by anion-exchange chromatography, gel filtration and FPLC. The inactivation of beta-lactamase activity was determined spectrophotometrically with nitrocefin as substrate. Various concentrations of the inhibitors were preincubated at 30 degrees C together with the enzyme for different periods of time before determination of the beta-lactamase activity. The three beta-lactamases tested were more susceptible to tazobactam than to clavulanic acid and sulbactam. Clavulanic acid and sulbactam reduced the enzyme activity of the Bacteroides uniformis beta-lactamase more effectively than the Clostridium butyricum and Fusobacterium nucleatum beta-lactamases.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF01967805DOI Listing

Publication Analysis

Top Keywords

acid sulbactam
12
beta-lactamase inhibitors
8
bacteroides uniformis
8
clostridium butyricum
8
butyricum fusobacterium
8
fusobacterium nucleatum
8
beta-lactamase activity
8
clavulanic acid
8
beta-lactamase
5
beta-lactamases
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!